Literature DB >> 10779323

Role of the cyclic AMP response element binding complex and activation of mitogen-activated protein kinases in synergistic activation of the glycoprotein hormone alpha subunit gene by epidermal growth factor and forskolin.

M S Roberson1, M Ban, T Zhang, J M Mulvaney.   

Abstract

The aim of these studies was to elucidate a role for epidermal growth factor (EGF) signaling in the transcriptional regulation of the glycoprotein hormone alpha subunit gene, a subunit of chorionic gonadotropin. Studies examined the effects of EGF and the adenylate cyclase activator forskolin on the expression of a transfected alpha subunit reporter gene in a human choriocarcinoma cell line (JEG3). At maximal doses, administration of EGF resulted in a 50% increase in a subunit reporter activity; forskolin administration induced a fivefold activation; the combined actions of EGF and forskolin resulted in synergistic activation (greater than eightfold) of the alpha subunit reporter. Mutagenesis studies revealed that the cyclic AMP response elements (CRE) were required and sufficient to mediate EGF-forskolin-induced synergistic activation. The combined actions of EGF and forskolin resulted in potentiated activation of extracellular signal-regulated kinase (ERK) enzyme activity compared with EGF alone. Specific blockade of ERK activation was sufficient to block EGF-forskolin-induced synergistic activation of the alpha subunit reporter. Pretreatment of JEG3 cells with a p38 mitogen-activated protein kinase inhibitor did not influence activation of the alpha reporter. However, overexpression of c-Jun N-terminal kinase (JNK)-interacting protein 1 as a dominant interfering molecule abolished the synergistic effects of EGF and forskolin on the alpha subunit reporter. CRE binding studies suggested that the CRE complex consisted of CRE binding protein and EGF-ERK-dependent recruitment of c-Jun-c-Fos (AP-1) to the CRE. A dominant negative form of c-Fos (A-Fos) that specifically disrupts c-Jun-c-Fos DNA binding inhibited synergistic activation of the alpha subunit. Thus, synergistic activation of the alpha subunit gene induced by EGF-forskolin requires the ERK and JNK cascades and the recruitment of AP-1 to the CRE binding complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10779323      PMCID: PMC85626          DOI: 10.1128/MCB.20.10.3331-3344.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  85 in total

1.  Tissue-specific enhancer of the human glycoprotein hormone alpha-subunit gene: dependence on cyclic AMP-inducible elements.

Authors:  A M Delegeane; L H Ferland; P L Mellon
Journal:  Mol Cell Biol       Date:  1987-11       Impact factor: 4.272

Review 2.  Glycoprotein hormones: structure and function.

Authors:  J G Pierce; T F Parsons
Journal:  Annu Rev Biochem       Date:  1981       Impact factor: 23.643

3.  12-O-tetradecanoyl phorbol-13-acetate potentiates adenosine 3',5'-monophosphate-mediated chorionic gonadotropin secretion by cultured human choriocarcinoma cells.

Authors:  O Ritvos; J Jalkanen; I Huhtaniemi; U H Stenman; H Alfthan; T Ranta
Journal:  Endocrinology       Date:  1987-04       Impact factor: 4.736

4.  Cyclic AMP regulates transcription of the genes encoding human chorionic gonadotropin with different kinetics.

Authors:  A Milsted; R P Cox; J H Nilson
Journal:  DNA       Date:  1987-06

5.  Cyclic AMP responsiveness of human gonadotropin-alpha gene transcription is directed by a repeated 18-base pair enhancer. Alpha-promoter receptivity to the enhancer confers cell-preferential expression.

Authors:  P J Deutsch; J L Jameson; J F Habener
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

6.  Effects of epidermal growth factor, phorbol myristate acetate, and arachidonic acid on choriogonadotropin secretion by cultured human choriocarcinoma cells.

Authors:  J Ilekis; R Benveniste
Journal:  Endocrinology       Date:  1985-06       Impact factor: 4.736

7.  A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation.

Authors:  M J Robinson; S A Stippec; E Goldsmith; M A White; M H Cobb
Journal:  Curr Biol       Date:  1998-10-22       Impact factor: 10.834

8.  Epidermal growth factor induces differentiation and secretion of human chorionic gonadotropin and placental lactogen in normal human placenta.

Authors:  D W Morrish; D Bhardwaj; L K Dabbagh; H Marusyk; O Siy
Journal:  J Clin Endocrinol Metab       Date:  1987-12       Impact factor: 5.958

9.  Firefly luciferase gene: structure and expression in mammalian cells.

Authors:  J R de Wet; K V Wood; M DeLuca; D R Helinski; S Subramani
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

10.  Cyclic AMP regulation of the human glycoprotein hormone alpha-subunit gene is mediated by an 18-base-pair element.

Authors:  B J Silver; J A Bokar; J B Virgin; E A Vallen; A Milsted; J H Nilson
Journal:  Proc Natl Acad Sci U S A       Date:  1987-04       Impact factor: 11.205

View more
  9 in total

1.  CCAAT/enhancer-binding proteins are key regulators of human type two deiodinase expression in a placenta cell line.

Authors:  Gianluca Canettieri; Maria Giulia Santaguida; Laura Antonucci; Michele Della Guardia; Antonella Franchi; Sonia Coni; Alberto Gulino; Marco Centanni
Journal:  Endocrinology       Date:  2012-06-11       Impact factor: 4.736

2.  Activation of thyroid hormone is transcriptionally regulated by epidermal growth factor in human placenta-derived JEG3 cells.

Authors:  Gianluca Canettieri; Antonella Franchi; Michele Della Guardia; Ianessa Morantte; Maria Giulia Santaguida; John W Harney; P Reed Larsen; Marco Centanni
Journal:  Endocrinology       Date:  2007-11-08       Impact factor: 4.736

3.  De novo truncating variants in PHF21A cause intellectual disability and craniofacial anomalies.

Authors:  Kohei Hamanaka; Yuji Sugawara; Takeyoshi Shimoji; Tone Irene Nordtveit; Mitsuhiro Kato; Mitsuko Nakashima; Hirotomo Saitsu; Toshimitsu Suzuki; Kazuhiro Yamakawa; Ingvild Aukrust; Gunnar Houge; Satomi Mitsuhashi; Atsushi Takata; Kazuhiro Iwama; Ahmed Alkanaq; Atsushi Fujita; Eri Imagawa; Takeshi Mizuguchi; Noriko Miyake; Satoko Miyatake; Naomichi Matsumoto
Journal:  Eur J Hum Genet       Date:  2018-11-28       Impact factor: 4.246

4.  Epidermal growth factor-induced GnRH-II synthesis contributes to ovarian cancer cell invasion.

Authors:  Song Ling Poon; Gareth T Hammond; Peter C K Leung
Journal:  Mol Endocrinol       Date:  2009-07-16

5.  cJun modulates Ggamma-globin gene expression via an upstream cAMP response element.

Authors:  Sirisha Kodeboyina; Parimaladevi Balamurugan; Li Liu; Betty S Pace
Journal:  Blood Cells Mol Dis       Date:  2009-10-27       Impact factor: 3.039

6.  Endothelin (ET)-1 and ET-3 promote expression of c-fos and c-jun in human choriocarcinoma via ET(B) receptor-mediated G(i)- and G(q)-pathways and MAP kinase activation.

Authors:  A Rauh; W Windischhofer; A Kovacevic; T DeVaney; E Huber; M Semlitsch; H-J Leis; W Sattler; E Malle
Journal:  Br J Pharmacol       Date:  2008-03-24       Impact factor: 8.739

7.  3', 5'-cyclic adenosine 5'-monophosphate response element-dependent transcriptional regulation of the secretogranin II gene promoter depends on gonadotropin-releasing hormone-induced mitogen-activated protein kinase activation and the transactivator activating transcription factor 3.

Authors:  Jianjun Xie; Mark S Roberson
Journal:  Endocrinology       Date:  2007-10-25       Impact factor: 4.736

8.  Pulsatile gonadotropin-releasing hormone stimulation of gonadotropin subunit transcription in rat pituitaries: evidence for the involvement of Jun N-terminal kinase but not p38.

Authors:  D J Haisenleder; L L Burger; H E Walsh; J Stevens; K W Aylor; M A Shupnik; J C Marshall
Journal:  Endocrinology       Date:  2007-10-11       Impact factor: 4.736

9.  Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells.

Authors:  Xuesen Zhang; Matthew J Gamble; Sonja Stadler; Brian D Cherrington; Corey P Causey; Paul R Thompson; Mark S Roberson; W Lee Kraus; Scott A Coonrod
Journal:  PLoS Genet       Date:  2011-06-02       Impact factor: 5.917

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.